Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-02 @ 1:56 PM
Study NCT ID:
NCT00150657
Status:
UNKNOWN
Last Update Posted:
2005-11-29
First Post:
2005-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
Sponsor:
St. John Providence Health System
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AVF3121s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None